Literature DB >> 10918673

The acute myocardial infarction.

T J Pollard1.   

Abstract

Cardiovascular death is the number one cause of death in the United States, with a rate that is more than double that for cancer. Over half of these cardiovascular deaths are due to acute myocardial infarction. Management of the patient with acute myocardial infarction during and after hospitalization is discussed with an emphasis on primary and secondary prevention, patient autonomy and decision making. There is also a review of the directions that treatment of acute myocardial infarction will take in the future.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10918673     DOI： 10.1016/s0095-4543(05)70167-6

Source DB:  PubMed          Journal:  Prim Care        ISSN： 0095-4543            Impact factor:   2.907


  11 in total

1.  Photobiomodulation Drives MiR-136-5p Expression to Promote Injury Repair after Myocardial Infarction.

Authors:  Xinlu Gao; Hanjing Li; Wenwen Zhang; Xiuxiu Wang; Hongyue Sun; Yang Cao; Yiming Zhao; Haoyu Ji; Fan Yang; Wenya Ma; Yu Liu; Baofeng Yang; Benzhi Cai
Journal:  Int J Biol Sci       Date:  2022-04-18       Impact factor: 10.750

2.  Circ_0030235 knockdown protects H9c2 cells against OGD/R-induced injury via regulation of miR-526b.

Authors:  Yuquan Zhang; Shuzhu Liu; Limin Ding; Dawei Wang; Qiangqiang Li; Dongdong Li
Journal:  PeerJ       Date:  2021-11-16       Impact factor: 2.984

3.  Intelligent Algorithm-Based Coronary Angiography Characteristics of Acute Non-ST-Segment Elevation Myocardial Infarction Patients with Different Genders.

Authors:  Yulong Cui; Hui Wang; Peng Peng; Feng Zhang; Qing Liu; Guangyang Zhao
Journal:  Comput Math Methods Med       Date:  2022-02-07       Impact factor: 2.238

4.  LRG1 promotes hypoxia-induced cardiomyocyte apoptosis and autophagy by regulating hypoxia-inducible factor-1α.

Authors:  Jiajie Feng; Jiachen Zhan; Shuangshuang Ma
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  The Clinical Efficacy of Tirofiban Combined with Ticagrelor and Aspirin in Treating Acute Myocardial Infarction by Percutaneous Coronary Intervention and Its Effect on Patients' Cardiac Function.

Authors:  Rui Peng; Feng Li
Journal:  J Healthc Eng       Date:  2022-02-09       Impact factor: 2.682

6.  CPE Regulates Proliferation and Apoptosis of Primary Myocardial Cells Mediated by Ischemia and Hypoxia Injury.

Authors:  Jin Li; Zishuang Dong; Yuxiong Pan; Luchen Wang; Wei Zhao
Journal:  J Healthc Eng       Date:  2022-03-16       Impact factor: 2.682

7.  Transcription factor JDP2 activates PDE4B to participate in hypoxia/reoxygenation-induced H9c2 cell injury.

Authors:  Suipeng Li; Yong Chen; Yinfeng Jia; Tingting Xue; Xuqing Hou; Zhangyin Zhao
Journal:  Exp Ther Med       Date:  2022-03-22       Impact factor: 2.447

8.  A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction.

Authors:  Mengnan Zhao; Dan Zhao; Yuning Li; Xiaonan Wang; Boyu Yi; Bo Zhou
Journal:  Front Cardiovasc Med       Date:  2022-02-28

9.  LncRNA HOTTIP Knockdown Attenuates Acute Myocardial Infarction via Regulating miR-92a-2/c-Met Axis.

Authors:  Beilei Wang; Likun Ma; Junyi Wang
Journal:  Cardiovasc Toxicol       Date:  2022-01-19       Impact factor: 3.231

10.  CTRP13 Protects H9c2 Cells Against Hypoxia/Reoxygenation (H/R)-Induced Injury Via Regulating the AMPK/Nrf2/ARE Signaling Pathway.

Authors:  Weifeng Jiang; Jungang Song; Suitao Zhang; Yanyan Ye; Jun Wang; Yilin Zhang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.